These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 20646322)

  • 1. Self-assembly of virus-like particles of porcine circovirus type 2 capsid protein expressed from Escherichia coli.
    Yin S; Sun S; Yang S; Shang Y; Cai X; Liu X
    Virol J; 2010 Jul; 7():166. PubMed ID: 20646322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of porcine circovirus type 2 (PCV2) capsid particle assembly and its application to virus-like particle vaccine development.
    Wu PC; Lin WL; Wu CM; Chi JN; Chien MS; Huang C
    Appl Microbiol Biotechnol; 2012 Sep; 95(6):1501-7. PubMed ID: 22526782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient expression and purification of porcine circovirus type 2 virus-like particles in Escherichia coli.
    Wu PC; Chen TY; Chi JN; Chien MS; Huang C
    J Biotechnol; 2016 Feb; 220():78-85. PubMed ID: 26795354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimized production of full-length PCV2d virus-like particles in Escherichia coli: A cost-effective and high-yield approach for potential vaccine antigen development.
    Zhang C; He F; Li N; Du W; Wen J; Wu X; Shi J; Li C; Liu C; Xu S; Han H; Hrabchenko N; Han X; Li J
    Microb Pathog; 2024 May; 190():106630. PubMed ID: 38556102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation in yeast of recombinant virus-like particles of porcine circovirus type 2 capsid protein and their use for a serologic assay and development of monoclonal antibodies.
    Nainys J; Lasickiene R; Petraityte-Burneikiene R; Dabrisius J; Lelesius R; Sereika V; Zvirbliene A; Sasnauskas K; Gedvilaite A
    BMC Biotechnol; 2014 Dec; 14():100. PubMed ID: 25487652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification of recombinant virus-like particles of porcine circovirus type 2 capsid protein using ion-exchange monolith chromatography.
    Zaveckas M; Snipaitis S; Pesliakas H; Nainys J; Gedvilaite A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Jun; 991():21-8. PubMed ID: 25910233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and characterization of immunogenic recombinant virus-like particles of porcine circovirus type 2 expressed in silkworm pupae.
    Masuda A; Lee JM; Miyata T; Sato T; Hayashi S; Hino M; Morokuma D; Karasaki N; Mon H; Kusakabe T
    J Gen Virol; 2018 Jul; 99(7):917-926. PubMed ID: 29851377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of Postweaning Multisystemic Wasting Syndrome-Associated Clinical Symptoms by Virus-Like Particle Vaccine Against Porcine Parvovirus and Porcine Circovirus Type 2.
    Liu G; Qiao X; Chang C; Hua T; Wang J; Tang B; Zhang D
    Viral Immunol; 2020; 33(6):444-456. PubMed ID: 32255758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Carboxyl Terminus of the Porcine Circovirus Type 2 Capsid Protein Is Critical to Virus-Like Particle Assembly, Cell Entry, and Propagation.
    Zhan Y; Yu W; Cai X; Lei X; Lei H; Wang A; Sun Y; Wang N; Deng Z; Yang Y
    J Virol; 2020 Apr; 94(9):. PubMed ID: 32075927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient production of porcine circovirus virus-like particles using the nonconventional yeast Kluyveromyces marxianus.
    Duan J; Yang D; Chen L; Yu Y; Zhou J; Lu H
    Appl Microbiol Biotechnol; 2019 Jan; 103(2):833-842. PubMed ID: 30421111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The preparation of porcine circovirus type 2 (PCV2) virus-like particles using a recombinant pseudorabies virus and its application to vaccine development.
    Chi JN; Wu CY; Chien MS; Wu PC; Wu CM; Huang C
    J Biotechnol; 2014 Jul; 181():12-9. PubMed ID: 24739460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterologous expression of full-length capsid protein of porcine circovirus 2 in Escherichia coli and its potential use for detection of antibodies.
    Marcekova Z; Psikal I; Kosinova E; Benada O; Sebo P; Bumba L
    J Virol Methods; 2009 Dec; 162(1-2):133-41. PubMed ID: 19664658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of virus-like particles for porcine circovirus type 2 by YeastFab Assembly.
    Chen P; Zhang L; Chang N; Shi P; Gao T; Zhang L; Huang J
    Virus Genes; 2018 Apr; 54(2):246-255. PubMed ID: 29417333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient application of a baculovirus-silkworm larvae expression system for obtaining porcine circovirus type 2 virus-like particles for a vaccine.
    He Q; Cao Z; Wang P; Lu Q; Zheng H; Sun J
    Arch Virol; 2020 Oct; 165(10):2301-2309. PubMed ID: 32757056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Porcine circovirus type 2 protective epitope densely carried by chimeric papaya ringspot virus-like particles expressed in Escherichia coli as a cost-effective vaccine manufacture alternative.
    Aguilera BE; Chávez-Calvillo G; Elizondo-Quiroga D; Jimenez-García MN; Carrillo-Tripp M; Silva-Rosales L; Hernández-Gutiérrez R; Gutiérrez-Ortega A
    Biotechnol Appl Biochem; 2017 May; 64(3):406-414. PubMed ID: 26970530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of immune effects of porcine circovirus type 2d (PCV2d) capsid protein expressed by Escherichia coli and baculovirus-insect cells.
    Wang Y; Xu F; Yuan C; Zhang Y; Ren J; Yue H; Ma T; Song Q
    Vaccine; 2024 Apr; 42(11):2848-2857. PubMed ID: 38514351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of Escherichia coli-based virus-like particle vaccine against porcine circovirus type 2 challenge in piglets: Structure characterization and protective efficacy validation.
    Xi X; Mo X; Xiao Y; Yin B; Lv C; Wang Y; Sun Z; Yang Q; Yao Y; Xuan Y; Li X; Yuan YA; Tian K
    J Biotechnol; 2016 Apr; 223():8-12. PubMed ID: 26907669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-Based Design of Porcine Circovirus Type 2 Chimeric VLPs (cVLPs) Displays Foreign Peptides on the Capsid Surface.
    Wang D; Zhang S; Zou Y; Yu W; Jiang Y; Zhan Y; Wang N; Dong Y; Yang Y
    Front Cell Infect Microbiol; 2018; 8():232. PubMed ID: 30038901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporation of a truncated form of flagellin (TFlg) into porcine circovirus type 2 virus-like particles enhances immune responses in mice.
    Liu X; Liu Y; Zhang Y; Zhang F; Du E
    BMC Vet Res; 2020 Feb; 16(1):45. PubMed ID: 32028949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanovaccine Confers Dual Protection Against Influenza A Virus And Porcine Circovirus Type 2.
    Ding P; Jin Q; Chen X; Yang S; Guo J; Xing G; Deng R; Wang A; Zhang G
    Int J Nanomedicine; 2019; 14():7533-7548. PubMed ID: 31571862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.